REG - Iofina PLC - Change of Adviser

IofinaAnnouncement

21/11/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221121:nRSU9588Ga&default-theme=true

RNS Number : 9588G  Iofina PLC  21 November 2022

21 November 2022

 

Iofina plc

("Iofina", the "Company" or the "Group")

(LSE AIM: IOF)

 

Change of Adviser

 

Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, today announces the appointment
of Canaccord Genuity Limited as the Company's Nominated Adviser and Corporate
Broker, with immediate effect.

 

 

 

Enquiries:

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Henry Fitzgerald-O'Connor

Patrick Dolaghan

Canaccord Genuity Limited -Nomad and Broker

Tel: +44 (0)20 7523 8000

 

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4761

 

Media Contact:

Charles Goodwin/Laurie Gellhorn

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221

About Iofina:

www.iofina.com (http://www.iofina.com)

 

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates five
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen specialty chemicals
derived from raw iodine, as well as non-iodine based products for over 38
years.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPGZMMMKRGGZZM